HDAC9 and cancer: Moreover, the combination of HDAC inhibitors and other chemotherapy drugs could not only exploit the synergistic action of both compounds, but it could also allow the use of lower doses, with a significant decrease in their respective toxicities and a reduction in cancer cell drug resistance.